Clinical Trials
All Clinical Trials - Page 23 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06185361N/AUnknown
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
Desmopressin
- NCT05564039Phase 4Completed
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
Tirzepatide
- NCT05768945N/ACompleted
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Semaglutide
- NCT05107219Phase 1Completed
GCC Agonist Signal in the Small Intestine
Linaclotide
- NCT06217848EARLY_Phase 1Unknown
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Liraglutide
- NCT05598008N/ACompleted
Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
Liraglutide
- NCT05617664N/AUnknown
Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis
Desmopressin
- NCT05347147Phase 3Terminated
A Trial to Determine the Efficacy and Safety of Presendin in IIH
Exenatide
- NCT05611957Phase 1Completed
A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
Retatrutide
- NCT05616013Phase 2Completed
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
Semaglutide
- NCT05623839Phase 1Completed
A Study of LY3305677 in Participants With Obesity Or Overweight
Mazdutide
- NCT05607680Phase 3Completed
A Study of IBI362 in Participants With Obesity or Overweight
Mazdutide
- NCT05582096Phase 1Completed
A Study of LY3457263 in Obese Participants
Tirzepatide
- NCT05613387Phase 1Completed
A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants
Petrelintide
- NCT05448547Phase 3Recruiting
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Gonadorelin
- NCT05567796Phase 3Active Not Recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Semaglutide
- NCT05582499Phase 2Recruiting
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
Gonadorelin
- NCT05387603Phase 3Recruiting
Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.
Octreotide
- NCT05579977Phase 2Terminated
Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity
Semaglutide
- NCT05195944Phase 4Active Not Recruiting
Semaglutide vs Sitagliptin
Semaglutide
- NCT05548231Phase 1Completed
A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
Retatrutide
- NCT04466566Phase 3Completed
A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics
Liraglutide
- NCT05573230Phase 1Completed
A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
Orforglipron
- NCT05567731N/ACompleted
Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve
Gonadorelin
- NCT05516966Phase 1Completed
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus
Dulaglutide
- NCT05556512Phase 3Active Not Recruiting
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
Tirzepatide
- NCT05254314Phase 2Active Not Recruiting
Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
Semaglutide
- NCT05564117Phase 3Completed
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
Semaglutide
- NCT05210582Phase 2Unknown
A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face
Afamelanotide
- NCT05313529N/ACompleted
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
Liraglutide
- NCT05530577Phase 2Completed
Effects of Semaglutide on Nicotine Intake
Semaglutide
- NCT05766358N/ACompleted
Role Of Metabolic Adaptation In Weight Regain
Tirzepatide
- NCT05444153Phase 3Withdrawn
Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity
Semaglutide
- NCT05205928Phase 2/Phase 3Completed
Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
Semaglutide
- NCT05658692Phase 4Unknown
Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
Thymosin-Alpha-1
- NCT04885634Phase 3Withdrawn
Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
Semaglutide
- NCT05473286N/AWithdrawn
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Semaglutide
- NCT05390892Phase 4Recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Semaglutide
- NCT05371496Phase 4Completed
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
Semaglutide
- NCT06027567Phase 4Completed
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
Semaglutide
- NCT05302596Phase 2Completed
Semaglutide Use in Elderly Obese Patients
Semaglutide
- NCT05340868N/ARecruiting
Genetics of the Acute Response to Oral Semaglutide
Semaglutide
- NCT05545800Phase 3Unknown
Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
Liraglutide
- NCT05438186N/AWithdrawn
INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records
Liraglutide
- NCT05517590N/ACompleted
Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.
Desmopressin
- NCT05467033Phase 3Recruiting
Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin
Desmopressin
- NCT05507476N/ACompleted
Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy
Desmopressin
- NCT05492305N/AUnknown
Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
Semaglutide
- NCT05459844Phase 3Active Not Recruiting
A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs
Octreotide
- NCT07028645N/AActive Not Recruiting
Uroflowmetry and Nocturnal Enuresis
Desmopressin